A 1b phase multi-dose escalating study (NCT04466904) targeting Chinese patients with type 2 diabetes showed that after 12 weeks of treatment with Mazdutide, the patients' glycated hemoglobin (HbA1c) levels significantly decreased, with a range of -1.46% to -2.23%, and the weight reduction could reach 5.4%
For research institutions in the UAE studying GLP-1 receptor biology in isolation, semaglutide provides a well-characterised single-receptor tool
Semaglutide can be an effective tool for weight loss when used correctly
Semaglutide works differently than many weight loss medications because it stays active in your bloodstream long after you take it
Indeed, I recently wrote about the fact that clinicians should be open to tweaking dose quantity and scheduling based on individual patients responses, rather than just monolithically concluding that a patient having nasty side effects in the dose escalation phase should just give up on the medications entirely
Visit us now to learn more about the benefits